Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
4
Neutral
1
Bullish
9
Bearish
36
Neutral
1
Bullish
9
Bearish
32
Neutral
0
Bullish
0
Bearish
4
Neutral
1
Bullish
9
Bearish
4
Neutral
1
Bullish
9
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Discovery themes featuring this stock| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
575.60 | 1,937 Cr | 364.12 | 2.92 | 0.09 | 0.50 | 4.36 | 0.45 | ||
125.60 | 1,739 Cr | 19.66 | 1.28 | 0.80 | 3.60 | 5.52 | 3.06 | ||
620.10 | 1,729 Cr | 778.99 | 36.88 | 0.00 | 2.90 | 5.84 | 1.53 | ||
325.85 | 1,683 Cr | 54.73 | 9.27 | 0.12 | 16.46 | 20.87 | 14.38 | ||
317.90 | 1,588 Cr | 29.82 | 4.84 | 0.94 | 14.93 | 18.30 | 12.72 | ||
80.36 | 1,544 Cr | -23.85 | 1.49 | 0.00 | 1.18 | 3.77 | 0.03 | ||
619.45 | 1,527 Cr | 32.30 | 2.96 | 0.40 | 9.15 | 11.04 | 6.91 | ||
| Median: 7 Co. | — | 325.85 | 1,683 Cr | 32.30 | 2.96 | 0.12 | 3.60 | 5.84 | 3.06 |
S H Kelkar & Company Ltd (SHK) is currently trading at 127.75 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
S H Kelkar & Company (Keva) manufactures, supplies and exports fragrances, flavours and aroma ingredients for personal care, home care, food and beverage industries, operating Creative Development Centres in India, Singapore and Europe and owning brands such as KEVA and Auris with manufacturing hubs in Vapi, Vashivali and international subsidiaries. In Q1 FY27 Keva reported consolidated revenue of Rs.662 crore, a 14% YoY increase, with consolidated EBITDA of Rs.89 crore and an EBITDA margin of 13.4%; the Flavours business delivered particularly strong growth (Rs.112 crore in Q1) while Global Ingredients lagged and Fragrances benefited from Europe-led momentum. Keva is mid-capital-cycle: European capex was completed and operational in Q1, India projects (Vanvate, Vashivali) are being commissioned with Vanvate expected in Q3; net debt rose to Rs.852 crore from strategic inventory build and capex, and management expects deleveraging from Q3 onwards as operations scale. Management remains cautiously optimistic: it expects double-digit revenue growth for FY27 and improved margins, while emphasising supply continuity, disciplined pricing and proactive raw-material inventory management (six months coverage) to insulate customers from volatility driven by geopolitical and freight disruptions.
Over the past 52 weeks, S H Kelkar & Company Ltd has traded between a low of ₹111.70 and a high of ₹229.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
S H Kelkar & Company Ltd has a market capitalization of approximately 1,738.57. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
S H Kelkar & Company Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 19.66 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,738.57 Cr, S H Kelkar & Company Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
S H Kelkar & Company Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of S H Kelkar & Company Ltd is 19.66. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Standalone revenue from operations for Q4FY26 was ₹336.43 crore, compared with ₹278.37 crore in Q4FY25, a 20.86% year-on-year increase.
S H Kelkar & Company (Keva) manufactures, supplies and exports fragrances, flavours and aroma ingredients for personal care, home care, food and beverage industries, operating Creative Development Centres in India, Singapore and Europe and owning brands such as KEVA and Auris with manufacturing hubs in Vapi, Vashivali and international subsidiaries.
In Q1 FY27 Keva reported consolidated revenue of Rs.662 crore, a 14% YoY increase, with consolidated EBITDA of Rs.89 crore and an EBITDA margin of 13.4%; the Flavours business delivered particularly strong growth (Rs.112 crore in Q1) while Global Ingredients lagged and Fragrances benefited from Europe-led momentum.
Keva is mid-capital-cycle: European capex was completed and operational in Q1, India projects (Vanvate, Vashivali) are being commissioned with Vanvate expected in Q3; net debt rose to Rs.852 crore from strategic inventory build and capex, and management expects deleveraging from Q3 onwards as operations scale.
Management remains cautiously optimistic: it expects double-digit revenue growth for FY27 and improved margins, while emphasising supply continuity, disciplined pricing and proactive raw-material inventory management (six months coverage) to insulate customers from volatility driven by geopolitical and freight disruptions.
Chemicals & Petrochemicals
Specialty Chemicals
1,739 Cr
High Risk
19.7
35.0
1.4
1.3
229.20
111.70
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: Nov 01, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
